

The Biosimilars LatAm – Brazil 2022 is looking forward to providing in-depth regional analysis and information regarding commercialization strategies, regulation, good manufacturing and distribution practices, international market trends and more.
With a particular focus on providing the insight about the clinical practice and prescription of these drugs in the country, seeking for a greater access to biological treatments for patients in Brazil.

Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Program at a Glance
Greater Access to Safe and Effective Life- saving Medications
Tendering Procedures: Healthy Competition and Public Health
GVP Case Study for an Specific Disease
The best-practices and improvement overview directly from Healthcare professionals to secure the traceability of medicaments and ability to track the patient’s medical journey. Securing the ability to reacting promptly in case any adverse-effects happen and be able to change the cure knowing exactly the root of the problem
Self-awareness Education: Patient Centered Communication
Regulatory Convergence and Harmonization
Prescribing Behaviours of Biosimilar Medicines
Full programme in the PDF Agenda
Download Agenda

Sponsors
Photo Gallery from Previous Events
